Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-27 23:04 | 2014-03-26 | CROL | N/A | Barnes R. Wayne | Director | Other | BUY | $5,817.00 | 5,817 | $33,837,489 | 15,817 | +58.2% |
| 2014-03-28 00:10 | 2014-03-26 | VSAR | Aravive, Inc. | Advent Life Sciences LLP | 10% owner | Pharmaceutical Preparations | BUY | $21.00 | 60,000 | $1,260,000 | 2,216,558 | +2.8% |
| 2014-03-28 00:12 | 2014-03-26 | VSAR | Aravive, Inc. | Malik Shahzad | Director, 10% owner | Pharmaceutical Preparations | BUY | $21.00 | 60,000 | $1,260,000 | 2,216,558 | +2.8% |
| 2014-03-28 01:36 | 2014-03-26 | VSAR | Aravive, Inc. | SUN ANTHONY Y | Director, 10% owner | Pharmaceutical Preparations | BUY | $21.00 | 60,000 | $1,260,000 | 1,994,568 | +3.1% |
| 2014-03-27 23:00 | 2014-03-25 | AKBA | Akebia Therapeutics Inc. | Satter Muneer A | Director | Pharmaceutical Preparations | BUY | $17.00 | 91,295 | $1,552,015 | 1,532,560 | +6.3% |
| 2014-03-27 23:02 | 2014-03-25 | AKBA | Akebia Therapeutics Inc. | Novartis Bioventures Ltd | 10% owner | Pharmaceutical Preparations | BUY | $17.00 | 182,590 | $3,104,030 | 182,590 | +100.0% |
| 2014-03-28 01:34 | 2014-03-26 | VSAR | Aravive, Inc. | AISLING CAPITAL III LP | 10% owner | Pharmaceutical Preparations | BUY | $21.00 | 60,000 | $1,260,000 | 1,994,568 | +3.1% |
| 2014-03-27 17:56 | 2014-03-25 | ALNY | Alnylam Pharmaceuticals Inc. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $66.88 | 344,448 | $23,036,682 | 9,110,786 | +3.9% |
| 2014-03-27 00:44 | 2014-03-25 | AKBA | Akebia Therapeutics Inc. | Novo A/S | 10% owner, Other | Pharmaceutical Preparations | BUY | $17.00 | 182,590 | $3,104,030 | 1,516,387 | +13.7% |
| 2014-03-27 01:03 | 2014-03-24 | BH | N/A | BIGLARI, SARDAR | Director, Officer, 10% owner - Chairman and CEO | Other | BUY | $496.66 | 6,076 | $3,017,732 | 25,552 | +31.2% |
| 2014-03-25 18:12 | 2014-03-24 | NHF | NEXPOINT DIVERSIFIED REAL ESTATE TRUST | DONDERO JAMES D | Other | Real Estate Investment Trusts | BUY | $11.52 | 113,643 | $1,309,164 | 3,367,279 | +3.5% |
| 2014-03-26 01:11 | 2014-03-24 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $307.91 | 306,945 | $94,511,742 | 18,790,310 | +1.7% |
| 2014-03-26 01:10 | 2014-03-21 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $321.22 | 305,115 | $98,008,216 | 18,483,365 | +1.7% |
| 2014-03-26 01:14 | 2014-03-24 | NSH | N/A | GREEHEY WILLIAM E | Director, 10% owner | Other | BUY | $32.12 | 34,383 | $1,104,320 | 8,218,198 | +0.4% |
| 2014-03-25 01:42 | 2014-03-20 | HMTVA | N/A | Luxor Capital Group, LP | 10% owner | Other | BUY | $10.74 | 383,500 | $4,116,911 | 1,781,903 | +27.4% |
| 2014-03-24 22:41 | 2014-03-20 | NSH | N/A | GREEHEY WILLIAM E | Director, 10% owner | Other | BUY | $32.49 | 30,815 | $1,001,330 | 8,183,815 | +0.4% |
| 2014-03-22 00:04 | 2014-03-20 | AGCO | AGCO Corporation | SRINIVASAN MALLIKA | Director | Farm Machinery & Equipment | BUY | $51.91 | 253,747 | $13,173,022 | 5,671,950 | +4.7% |
| 2014-03-21 21:44 | 2014-03-19 | N/A | N/A | Centerbridge Credit Partners, L.P. | 10% owner, Other | Other | BUY | $85.00 | 13,200 | $1,122,000 | 1,266,092 | +1.1% |
| 2014-03-21 17:56 | 2014-03-20 | PSEC | PROSPECT CAPITAL CORP | Barry John F | Director, Officer - CHIEF EXECUTIVE OFFICER | Other | BUY | $10.86 | 100,000 | $1,086,000 | 3,793,385 | +2.7% |
| 2014-03-22 03:23 | 2014-03-19 | CSLT | N/A | MAVERICK CAPITAL LTD | 10% owner | Other | BUY | $16.00 | 450,000 | $7,200,000 | 450,000 | +100.0% |
| 2014-03-22 03:56 | 2014-03-21 | SANW | S&W Seed Company | WICKERSHAM GROVER T | Director | Agricultural Production-Crops | BUY | $6.87 | 150,000 | $1,030,500 | 360,000 | +71.4% |
| 2014-03-21 23:07 | 2014-03-19 | CHK | EXPAND ENERGY Corp | DUNHAM ARCHIE W | Director | Crude Petroleum & Natural Gas | BUY | $24.97 | 54,250 | $1,354,655 | 1,111,499 | +5.1% |
| 2014-03-22 01:21 | 2014-03-19 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $328.33 | 67,703 | $22,229,163 | 18,178,250 | +0.4% |
| 2014-03-22 02:44 | 2014-03-19 | EQIX | EQUINIX INC | SPO ADVISORY CORP | 10% owner | Real Estate Investment Trusts | BUY | $180.19 | 325,000 | $58,561,295 | 5,207,900 | +6.7% |
| 2014-03-21 00:03 | 2014-03-19 | AGCO | AGCO Corporation | SRINIVASAN MALLIKA | Director | Farm Machinery & Equipment | BUY | $51.94 | 155,592 | $8,081,448 | 2,256,981 | +7.4% |
| 2014-03-21 02:33 | 2014-03-18 | DXLG | DESTINATION XL GROUP, INC. | MESDAG WILLEM | Director, 10% owner | Retail-Family Clothing Stores | BUY | $5.50 | 1,086,200 | $5,976,924 | 5,924,254 | +22.5% |
| 2014-03-20 19:07 | 2014-03-17 | STTH | Manufactured Housing Properties Inc. | Pioneer Group, LLC | 10% owner | Real Estate | BUY | $0.03 | 33,650,000 | $1,009,500 | 35,773,140 | +1,584.9% |
| 2014-03-21 02:14 | 2014-03-20 | FSFR | N/A | TANNENBAUM LEONARD M | Director, Officer - CEO | Other | BUY | $14.33 | 85,870 | $1,230,886 | 377,252 | +29.5% |
| 2014-03-21 00:16 | 2014-03-18 | HRG | Spectrum Brands Holdings, Inc. | LEUCADIA NATIONAL CORP | 10% owner | Miscellaneous Electrical Machinery, Equipment & Supplies | BUY | $11.00 | 23,000,000 | $253,000,000 | 41,632,180 | +123.4% |
| 2014-03-19 23:35 | 2014-03-18 | TMNG | N/A | Elutions, Inc. | 10% owner | Other | BUY | $3.28 | 609,756 | $2,000,000 | 609,756 | +100.0% |
| 2014-03-20 01:02 | 2014-03-18 | BJRI | BJs RESTAURANTS INC | Luxor Capital Group, LP | 10% owner | Retail-Eating Places | BUY | $34.94 | 265,800 | $9,286,706 | 313,596 | +556.1% |
| 2014-03-20 01:01 | 2014-03-17 | BJRI | BJs RESTAURANTS INC | Luxor Capital Group, LP | 10% owner | Retail-Eating Places | BUY | $34.36 | 190,867 | $6,558,476 | 286,496 | +199.6% |
| 2014-03-20 02:54 | 2014-03-17 | BJRI | BJs RESTAURANTS INC | Walsh Patrick | Other | Retail-Eating Places | BUY | $34.57 | 90,375 | $3,124,246 | 693,229 | +15.0% |
| 2014-03-19 01:58 | 2014-03-14 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $328.46 | 115,711 | $38,006,447 | 18,110,547 | +0.6% |
| 2014-03-17 23:44 | 2014-03-14 | AMRC | Ameresco Inc. | Sakellaris George P | Director, Officer, 10% owner - President and CEO | Construction - Special Trade Contractors | BUY | $7.75 | 166,130 | $1,286,777 | 2,470,156 | +7.2% |
| 2014-03-17 15:15 | 2014-03-14 | DRC | N/A | Volpe Vincent R JR | Director, Officer - President and CEO | Other | BUY | $54.75 | 18,400 | $1,007,400 | 175,271 | +11.7% |
| 2014-03-17 22:51 | 2014-03-14 | GKNT | N/A | LANGONE KENNETH G | Director, 10% owner | Other | BUY | $14.00 | 417,736 | $5,848,304 | 742,736 | +128.5% |
| 2014-03-18 00:52 | 2014-03-13 | NS | N/A | GREEHEY WILLIAM E | Director | Other | BUY | $52.26 | 19,334 | $1,010,341 | 2,384,613 | +0.8% |
| 2014-03-14 22:27 | 2014-03-12 | AQXP | Neurogene Inc. | PFIZER INC | 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 272,727 | $2,999,997 | 1,235,330 | +28.3% |
| 2014-03-15 00:11 | 2014-03-12 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $334.69 | 220,995 | $73,964,419 | 17,994,836 | +1.2% |
| 2014-03-15 02:26 | 2014-03-12 | PFSW | N/A | transcosmos inc. | 10% owner | Other | BUY | $9.69 | 317,845 | $3,079,282 | 3,610,094 | +9.7% |
| 2014-03-14 19:01 | 2014-03-11 | UTSI | UTSTARCOM HOLDINGS CORP. | SHAH CAPITAL MANAGEMENT | 10% owner | Communications Equipment, NEC | BUY | $2.67 | 2,000,000 | $5,340,000 | 8,426,057 | +31.1% |
| 2014-03-14 00:51 | 2013-12-06 | XNCR | Xencor Inc | STAFFORD JOHN S III | Director, 10% owner | Pharmaceutical Preparations | BUY | $5.50 | 275,000 | $1,512,500 | 7,558,631 | +3.8% |
| 2014-03-13 23:29 | 2014-03-11 | NS | N/A | GREEHEY WILLIAM E | Director | Other | BUY | $51.69 | 35,700 | $1,845,276 | 2,365,279 | +1.5% |
| 2014-03-13 23:28 | 2014-03-11 | NSH | N/A | GREEHEY WILLIAM E | Director, 10% owner | Other | BUY | $31.86 | 63,900 | $2,035,854 | 8,132,098 | +0.8% |
| 2014-03-13 04:15 | 2014-03-10 | VNRX | VOLITIONRX LTD | Innes Guy Archibald | Director | In Vitro & In Vivo Diagnostic Substances | BUY | $42,294.43 | 42,456 | $1,795,652,303 | 1,111,675 | +4.0% |
| 2014-03-13 04:01 | 2013-10-29 | RVEN | N/A | Allied Fortune (HK) Management Ltd | 10% owner | Other | BUY | $0.20 | 20,000,000 | $4,000,000 | 75,000,000 | +36.4% |
| 2014-03-13 00:42 | 2014-03-10 | GMCR | N/A | WESLEY NORMAN H | Director | Other | BUY | $105.06 | 11,000 | $1,155,628 | 10,000 | +100.0% |
| 2014-03-13 00:36 | 2014-03-10 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $330.41 | 380,532 | $125,730,779 | 17,773,841 | +2.2% |
| 2014-03-12 02:28 | 2014-03-07 | OVAS | Tempest Therapeutics, Inc. | Dipp Michelle | Director, Officer, 10% owner - President & CEO | Pharmaceutical Preparations | BUY | $10.00 | 100,000 | $1,000,000 | 3,820,571 | +2.7% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.